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T he rates of bladder cancer are highest in people aged 75-84 years,  with a median age of 73 at 
diagnosis [1].  Radical cystectomy with pelvic lymph 
node dissection is the gold standard treatment for mus-
cle-invasive bladder cancer (MIBC) and for selected 
patients with high-risk non-muscle-invasive disease 
(European association of Urology (EAU) guideline 2017 
https://urowb.rorg/guideline/bladder-cancer-muscle- 
invasive-and-metastatic/ (accessed September 1,  2018)).  
However,  open radical cystectomy (ORC) is a proce-
dure with high morbidity,  and it is associated with a 
high complication rate [2].  Among patients with mus-
cle invasion,  those aged 75 years and older were less 
likely to undergo radical cystectomy (14%) compared 
with patients aged 55-64 years (48%) and those aged 
65-74 years (43%).  Patient age may affect treatment 
decisions in patients with muscle-invasive disease [3].  
In recent reports,  laparoscopic radical cystectomy 
(LRC) has been shown to be a minimally invasive 
approach that limits blood loss and has the benefits of 
less postoperative pain and faster bowel function recov-
ery compared with ORC [4].  However,  the feasibility of 
LRC in very elderly patients remains unclear.  We per-
formed a comparative analysis of perioperative/clinical 
outcomes between elderly patients (≥ 75 years) and 
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Laparoscopic radical cystectomy (LRC) is a standard surgical treatment for muscle-invasive bladder cancer and 
high-risk non-muscle-invasive bladder cancer.  LRC is a less invasive modality than conventional open surgery.  
Therefore,  even elderly patients with invasive bladder cancer may be candidates for LRC.  In this study,  a com-
parative analysis of perioperative/oncological outcomes between elderly patients and younger patients who 
underwent LRC was performed to assess the feasibility of LRC in elderly patients.  Sixty-eight consecutive 
patients who underwent LRC between October 2013 and March 2018 were enrolled and stratified into those 
younger than 75 years (n = 37) and those ≥ 75 years old (n = 31).  The median follow-up period was 28.2 months.  
The preoperative and operative parameters and complications were similar in both groups.  The 2-year overall 
survival (OS) was 64.4% in the younger vs. 76.4% in the elderly group (p=0.053),  cancer-specific survival (CSS) 
was 79.3% vs. 81.7% (p=0.187),  and recurrence-free survival (RFS) was 58.2% vs. 75.7% (p=0.174),  respec-
tively.  No significant differences were observed in OS,  CSS,  or RFS between the groups.  No significant differ-
ences were found between the groups with respect to peri-surgical/oncological outcomes.  We conclude that 
LRC is feasible in elderly patients.
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younger patients (< 75 years) who underwent LRC.
Patients and Methods
A total of 68 consecutive patients who underwent 
LRC between October 2013 and March 2018 were 
reviewed and divided into 2 groups,  those who were 75 
years old or older (n = 31),  and those below 75 (n = 37),  
for comparison.  Both groups were assessed for periop-
erative outcomes,  including operating time,  blood loss,  
complications,  pathological findings,  recovery,  and 
oncological outcomes.  The oncological indication of 
radical cystectomy in our institute was high-risk 
non-muscle-invasive bladder cancer with BCG failure 
or MIBC.  The final surgical indication basically 
depended on the patient’s condition (American Society 
of Anesthesiologists (ASA) class < 2),  not on age.  The 
study design was approved by the Ethics Committee of 
Ehime University Hospital (No. 1806017),  and it 
adhered to the Declaration of Helsinki.
Statistical analysis. Comparisons between groups 
were performed using the Mann-Whitney U-test and 
chi-squared test.  The log-rank test was used to compare 
the Kaplan-Meier curves between the groups.  Asso-
ciations between variables and cancer-specific survival 
(CSS) were analyzed using Cox proportional hazards 
regression for CSS analysis,  with data summarized by 
hazard ratios with 95% confidence intervals (CIs).  All 
analyses were performed using the IBM Statistical 
Package for the Social Sciences (SPSS) version 21.0 
(IBM Corp.,  Armonk,  NY,  USA),  and values of p< 0.05 
were considered to indicate statistical significance.
Results
The cohort included 37 patients younger than 75 
years old and 31 patients (46%) 75 years old or older 
(Table 1).  The preoperative parameters (sex,  body 
mass index,  ASA class,  Charlson comorbidity index,  
performance status) were similar in both groups.  
However,  significant differences were observed in 
hemoglobin (p = 0.034),  albumin (p = 0.038),  and the 
neoadjuvant chemotherapy rate (p= 0.016) (Table 2).  As 
for intraoperative data,  the operative time (median 444 
vs. 442 min),  estimated blood loss (median 500 vs. 
380 mL),  and rate/range of pelvic lymphadenectomy 
were similar in both groups.  We performed construc-
tion of an ileal neobladder (27.0%) in the younger 
patients and ureterostomy (22.6%) in the elderly 
patients.  But no significant difference was observed in 
the distribution of urinary diversion (p = 0.562) (Table 
2).  The rates of peri-/postoperative complications of all 
grades (Clavien–Dindo classification) were 32.4% vs. 
29.0% (p = 0.577) and those of complications over grade 
3 were 16.2% vs. 9.7% in the younger and elderly 
groups,  respectively.  One patient from the elderly 
group needed intraoperative open conversion due to 
hypercapnia.  No other patients needed open conver-
sion (Table 3).  The pathological findings showed that 
the positive surgical margin rates (10.8% vs. 6.6% in the 
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Table 1　 Demographic and clinical characterstics
Elderly group (≧75)
n＝31
Younger group (75＜ )
n＝37 p-value
age median (range) 79 (75-90) 69 (37-74)
Sex (male : female) 22 : 9 30 : 7 0.327
BMI median (range) 24.2 (16.6-31.1) 22.3 (17-37.3) 0.104
ASA class (1/2/3) 11/19/1 20/16/1 0.304
CCI median (range) 1 (0-5) 0 (0-9) 0.421
PS (0/1/2/3) 17/11/1/1 29/8/0/0 0.102
Hb,  g/dl median (range) 11.6 (8.8-15.6) 12.6 (8.8-18.4) 0.034
Alb,  g/dl median (range) 3.8 (3.0-4.6) 4 (3.3-4.9) 0.038
cT (cT2 over) n,  (%) 25 (80.6) 34 (91.9) 0.158
cT (Tis/1/2/3/4) (2/4/14/9/2) (1/2/22/10/2) 0.677
cN(+) n,  (%) 3 (9.7) 2 (5.4) 0.415
cM1 n,  (%) 0 2 (5.4) 0.292
UC dominant n,  (%) 29 (93.5) 34 (91.9) 0.585
Neoadjuvant chemo n,  (%) 11 (35.5) 24 (64.9) 0.016
Follow-up,  m median (range) 35.4 (8.6-60.3) 23.5 (7.4-54.3) 0.044
younger vs.  elderly group,  respectively) and the distri-
butions of pathological stage were also similar between 
the groups.  The median follow-up period was 28.2 
months (Fig. 1).  The 2-year overall survival (OS) rate 
was 64.4% in the younger vs. 76.4% in the older group 
(p = 0.053),  the CSS rates were 79.3% and 81.7% 
(p = 0.187),  and the recurrence-free survival (RFS) rates 
were 58.2% and 75.7% (p = 0.174),  respectively.  No sig-
nificant differences in OS,  CSS,  or RFS between the 
younger and elderly groups were observed.  Table 4 
shows the Cox proportional hazards regression analysis 
for CSS.  In CSS,  the age,  sex,  LND,  cN(+),  NAC,  
≥ pT3,  and pN(+),  RM(+) were examined via univari-
able analysis.  Significant differences were found in 
≥ pT3 (hazard ratio (HR) 7.207,  95% CI 2.221-23.390,  
p = 0.001) and RM(+) (HR 5.791,  95% CI 1.803-18.597,  
p = 0.003).  In the multivariable analysis,  a significant 
difference was observed in ≥ pT3 (HR 4.496,  95% CI 
1.139-17.741,  p = 0.032),  but no significant differences 
were observed in age or RM(+).
Discussion
Radical cystectomy is the gold standard treatment 
for MIBC and for selected patients with high-risk 
non-muscle-invasive disease.  ORC is an invasive treat-
ment with higher rates of peri- and postoperative com-
plications (blood loss,  infection,  and ileus) in elderly 
patients compared with LRC [5].  In urological surgery,  
the standard urologic surgery method has switched 
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Table 2　 Operative data and pathological data
Elderly group (≧75)
n＝31
Younger group (75＜ )
n＝37 p-value
Operating time,  min median (range) 444 (312-640) 442 (279-595) 0.768
EBL,  ml (range) 500 (30-5,610) 380 (40-2,550) 0.392
Transfusion,  n (%) 14 (45.2) 13 (35.1) 0.4
LND,  n (%) 24 (77.4) 33 (89.2) 0.189
extended LND 12 (38.7) 22 (59.5) 0.088
Number of LN,  n median (range) 16.5 (0-30) 20 (4-37)  0.308
Urinary diversion,  n (%) 0.562
　　ileal conduit 18 (58.1) 21 (56.8)
　　ileal neobladder 6 (19.3) 10 (27.0)
　　uretrostomy 7 (22.6) 5 (13.5)
　　none 0 1 (2.7)
pT (0/Tis/1/2/3/4) (7/3/5/4/9/3) (9/6/5/3/10/4) 0.956
pN＋,  n (%) 3 (9.7) 5 (13.5) 0.46
RM1,  n (%) 2 (6.5) 4 (10.8) 0.425
Table 3　 Complications (peri/post operation)
Elderly group (≧75)
n＝31
Younger group (75＜)
n＝37 p-value
Perioperative complication 2 (6.5) 3 (8.1) 0.583
　　conversion (hypercapnia),  n 1 0
　　Rectal injury,  n 0 2
　　Obturator nerve injury,  n 1 0
　　Peroneal nerve palsy,  n 0 1
Post complication,  n (%) 9 (29.0) 12 (32.4) 0.315
　　Major (≧class Ⅲ),  n (%) 3 (9.7) 6 (16.2) 0.133
Ileus 2,  abscess 1 Ileus 3,  abscess 1
Anastomotic leak 1
Heart failure 1
　　Minor (≦class Ⅱ),  n (%) 6 (19.4) 6 (16.2)
Pyelonephritis,  SSI Pyelonephritis,  SSI,  ileus
from open operation to laparoscopic/robotic surgery.  
Some systematic reviews have reported that LRC is a 
feasible and safe alternative to ORC with less blood loss 
and a lower transfusion requirement,  a shorter length of 
hospital stay,  and fewer complications.  LRC does,  
however,  have longer operative times [6 , 7].  Our data 
showed that the operative times were longer,  but the 
complication rate was lower in the LRC in comparison 
with ORC,  as reported previously [7].  The results 
obtained at our institute were not inferior to those of 
European multicenter studies in terms of the incidence 
of complications compared [8].  Treatment decisions 
should not be based on chronology alone,  and 
advanced age should not be a factor that precludes 
aggressive or curative therapy [9].  Preoperative nutri-
tional status,  serum albumin level,  ASA class,  and 
physical status are essential factors and should be con-
sidered [10-12].  In elderly patients (75 years and older),  
it has been reported that LRC has low rates of complica-
tions (ileus,  infection).  However,  LRC has a longer 
operative time than ORC [5 , 13 , 14].
In a previous report,  robot-assisted radical cystec-
tomy (RARC) was shown to be associated with a lower 
rate of bleeding compared with ORC.  However,  its 
operative time was longer,  and the rate of occurrence of 
complications was the same [15].  In addition,  a ran-
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≧75 76.4％
＜75 64.4％
2 years
Log rank  p=0.053
Time (month)
Overall survival N=68 (all case)
≧75 75.7％
＜75 58.2％
2 years
Recurrence Free Survival
Log rank  p=0.174
Time (month)
Cancer Speciﬁc Survival
2 years ≧75 81.7％
＜75 79.3％
Log rank  p=0.187
Time (month)
No.at Risk
≧75 31 25 18 12 5 1
＜75 37 24 12 5 0 0
No.at Risk
≧75 31 25 18 12 5 1
＜75 37 24 11 5 0 0
No.at Risk
≧75 31 22 18 12 5 1
＜75 37 20 9 4 0 0
.0 12.0 24.0 36.0 48.0 60.0 72.0 .0 12.0 24.0 36.0 48.0 60.0 72.0 .0 12.0 24.0 36.0 48.0 60.0 72.0
Fig. 1　 Overall Survival,  Cancer Speciﬁc survival,  Recurrence Free Survival in LRC treatment.
Table 4　 Cox proportional hazards regression analysis of cancer speciﬁc survival
Univariable analysis Multivariable analysis
HR 95% CI p-value HR 95% CI p-value
Age≧75 (vs＜75) 2.073 0.686-6.259 0.196
Sex male (vs female) 2.171 0.485-9.706 0.311
　NAC 0.925 0.324-2.639 0.884
　LND 0.704 0.196-2.530 0.591
　cN (+) 2.419 0.539-10.859 0.249
≧pT3（vs＜pT2） 7.207 2.221-23.390 0.001 4.496 1.139-17.741 0.032
　pN (+) 3.568 0.982-12.967 0.053 2.619 0.614-11.170 0.193
　RM (+) 5.791 1.803-18.579 0.003 2.725 0.678-10.963 0.158
domized trial comparing ORC,  LRC,  and RARC 
demonstrated that LRC had fewer complications than 
ORC and a shorter operative time than RARC [16].  At 
present,  LRC remains the standard treatment for MIBC 
and selected patients with high-risk non-muscle-inva-
sive disease.
We have typically constructed an ileal neobladder 
and ileal conduit for urinary diversion,  and the selec-
tion of the diversion did not depend on the age of the 
patient.  In cases with a single kidney or with a low per-
formance status,  cutaneous ureterostomy was selected 
with the intention of decreasing the rate of complica-
tions and shortening the operative time [17 , 18].  As 
shown in a prior report [19],  an ileal conduit should be 
one of the standard urinary diversions for elderly 
patients undergoing radical cystectomy.  On the other 
hand,  cutaneous ureterostomy is also the procedure of 
choice for patients with limited dexterity,  poor motiva-
tion,  anatomical restrictions,  and poor renal function.
In our results,  prognostic parameters such as OS,  
CSS,  and RFS tended to be more predictive in elderly 
patients than in younger patients,  although the differ-
ences were not statistically significant.  This trend in 
prognosis was caused by a tendency for more younger 
patients to exhibit highly malignant disease (cT2 over,  
cM1,  pN+,  and RM1).
Several studies have evaluated various factors to 
determine the prognosis of MIBC.  Extravesical tumor 
(T3-T4),  advanced age,  non-urothelial variant histol-
ogy,  and a reduced number of lymph nodes removed 
have been established as poor prognostic factors for 
patients treated with radical cystectomy [8 , 20].  
Although the current study has some limitations 
including its small sample size and its retrospective 
design,  it found that advanced age was not a poor prog-
nostic factor.  Based on the results of our comparative 
analysis,  we conclude that LRC is a feasible treatment in 
elderly patients.  In conclusions,  no significant differ-
ences were observed between the 2 groups with respect 
to peri-surgical/oncological outcomes.  LRC in elderly 
patients was safe and had good results.  Thus,  LRC is 
feasible even in elderly patients.
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